Transposed Basilic Vein Versus Polytetrafluorethylene for Brachial-Axillary Arteriovenous Fistulas

Authors

John H. Matsuura, Wright State UniversityFollow
David Rosenthal
Michael D. Clark
Frederick W. Shuler
Lem Kirby
Michael Shotwell
Jerry Purvis
L. Laszlo Pallos

Document Type

Article

Publication Date

8-1998

Abstract

Background: Both transposed basilic vein (BV) and polytetrafluorethylene (PTFE) upper arm arteriovenous fistulas (AVF) are common angioaccess operations. To evaluate the patency and complication rates after AVF, a concurrent series of patients was reviewed.

Methods: Ninety-eight patients underwent brachial artery to axillary vein AVF: 30 BV and 68 PTFE. The PTFE grafts were performed in the standard fashion, whereas the basilic veins were translocated subcutaneously to the brachial artery.

Results: Risk factors were similar between the two groups. Basilic vein AVF had better patency at 24 months (70% BV versus 46% PTFE, P = 0.023). The dialysis access complications were higher in the BV group (20%) versus PTFE (5%), but the PTFE group had a higher infection rate (10%) than BV (0%).

Conclusions: The primary and secondary patency rates were superior in the BV AVFs. The BV AVF preserves the venous outflow tract after AVF thrombosis for a future PTFE AVF operation.

Comments

Presented at the 26th Annual Symposium on Vascular Surgery, Society for Clinical Vascular Surgery, San Diego, California, March 25–29, 1998.

Repository Citation

Matsuura, J. H., Rosenthal, D., Clark, M. D., Shuler, F. W., Kirby, L., Shotwell, M., Purvis, J., & Pallos, L. L. (1998). Transposed Basilic Vein Versus Polytetrafluorethylene for Brachial-Axillary Arteriovenous Fistulas. The American Journal of Surgery, 176 (2), 219-221.
https://corescholar.libraries.wright.edu/surg/505

DOI

10.1016/S0002-9610(98)00122-6